文献速递生殖医学

定义复发性妊娠丢失:两次与三次及以上妊娠丢失夫妇的相关因素及预后比较

Defining recurrent pregnancy loss: associated factors and prognosis in couples with two versus three or more pregnancy losses.
PubMed 文献 · Reprod Biomed Online · 2020-06-05

该单中心回顾性队列研究纳入2012至2016年莱顿大学医学中心复发性妊娠丢失门诊的383对夫妇,比较两次与三次及以上妊娠丢失夫妇的相关因素分布。结果显示71.5%的夫妇未发现相关因素,两组间无统计学差异(73.6% vs 70.6%;P=0.569),所调查病因的分布亦无差异。作者据此认为两次妊娠丢失夫妇应获得与三次者相同的诊疗路径,并支持ESHRE将两次妊娠丢失纳入定义的提议。

要点

  • 71.5%的复发性妊娠丢失夫妇未发现相关因素,两次与三次及以上妊娠丢失夫妇间无统计学差异(73.6% vs 70.6%;P=0.569)。
  • 所调查的子宫异常、抗磷脂综合征、遗传性血栓形成倾向、高同型半胱氨酸血症、染色体异常及甲状腺过氧化物酶抗体阳性的分布两组间无差异。
  • 作者认为两次妊娠丢失夫妇应获得与三次者相同的诊疗路径,并支持ESHRE将两次妊娠丢失纳入复发性妊娠丢失定义的提议。

核心结论

  • 两次与三次及以上妊娠丢失夫妇的相关因素分布相同,两次妊娠丢失夫妇应获得与三次者相同的诊疗路径。
  • 该研究支持ESHRE将两次妊娠丢失纳入复发性妊娠丢失定义的提议。

研究设计与样本

  • 单中心回顾性队列研究,纳入2012至2016年莱顿大学医学中心复发性妊娠丢失门诊的383对夫妇。
  • 收集年龄、体重指数、吸烟状态、妊娠丢失次数、平均至妊娠丢失时间及所行检查等资料。
  • 比较两次与三次及以上妊娠丢失夫妇中子宫异常、抗磷脂综合征、遗传性血栓形成倾向、高同型半胱氨酸血症、染色体异常及甲状腺过氧化物酶抗体阳性的患病率。

主要发现

  • 71.5%的复发性妊娠丢失夫妇未发现相关因素。
  • 未发现相关因素的比例在两次与三次及以上妊娠丢失夫妇间无统计学差异(73.6% vs 70.6%;P=0.569)。
  • 所调查病因的分布在两组间无差异。

临床怎么用

  • 作者认为两次妊娠丢失夫妇应获得与三次者相同的诊疗路径。
  • 该研究支持ESHRE将两次妊娠丢失纳入复发性妊娠丢失定义的提议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: The definition of recurrent pregnancy loss (RPL) differs internationally. The European Society of Human Reproduction and Embryology (ESHRE) defines RPL as two or more pregnancy losses. Different definitions lead, however, to different approaches to care for couples with RPL. This study aimed to determine whether the distribution of RPL-associated factors was different in couples with two versus three or more pregnancy losses. If a similar distribution were found, couples with two pregnancy losses should be eligible for the same care pathway as couples with three pregnancy losses. DESIGN: This single-centre, retrospective cohort study investigated 383 couples included from 2012 to 2016 at the Leiden University Medical Center RPL clinic. Details on age, body mass index, smoking status, number of pregnancy losses, mean time to pregnancy loss and performed investigations were collected. The prevalence of uterine anomalies, antiphospholipid syndrome, hereditary thrombophilia, hyperhomocysteinaemia, chromosomal abnormalities and positive thyroid peroxidase antibodies were compared in couples with two versus three or more pregnancy losses. RESULTS: No associated factor was found in 71.5% of couples with RPL. This did not differ statistically between couples with two versus three or more pregnancy losses (73.6% versus 70.6%; P = 0.569). The distribution of investigated causes did not differ between the two groups. CONCLUSIONS: As the distribution of associated factors in couples with two versus three or more pregnancy losses is equal, couples with two pregnancy losses should be eligible for the same care pathway as couples with three. This study supports ESHRE's suggestion of including two pregnancy losses in the definition of RPL.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Youssef A, Lashley L, Dieben S, et al. Defining recurrent pregnancy loss: associated factors and prognosis in couples with two versus three or more pregnancy losses. Reprod Biomed Online. 2020. PMID: 32811769. doi:10.1016/j.rbmo.2020.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。